Nurses in the Lead - Nursing Leadership and Autonomy in Function Focused Care in Hospital
Launched by LEIDEN UNIVERSITY MEDICAL CENTER · Mar 10, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The investigators will conduct a prospective before-after multicenter study, including a process evaluation, with a mixed methods approach in two university medical centers. In the preparation phase before the before-after study the tailored implementation strategy for FFCiH will be developed. Between the before and after phases of the study, the investigators will implement in two or three cyclic processes the FFCiH approach by strengthening nursing leadership and autonomy in the application of FFCiH in the interprofessional collaboration, using the predefined tailored implementation strat...
Gender
ALL
Eligibility criteria
- Nurses and student nurses (vocational nursing educational level (MBO)/ (bachelor nursing educational level (HBO)):
- Inclusion Criteria:
- • - All (student-)nurses working in the participating wards are expected to be involved in application of FFC and role development with regards to leadership and autonomy of nurses and therefore considered to be eligible for participation in the study.
- Exclusion Criteria:
- • - No exclusion criteria were defined for nurses and student nurses.
- • Physiotherapists, doctors and other member of the interprofessional team;
- Inclusion Criteria:
- • - All professional groups that are part of the interprofessional team of the ward and who work in the participating wards are expected to collaborate with the nursing in their daily care and therefore considered to be eligible for participation in this study.
- Exclusion Criteria:
- • - No exclusion criteria were defined for physiotherapists, doctors and other members of the interprofessional team.
- Patients and informal caregivers:
- Inclusion Criteria:
- • - All patients admitted to the participating wards of the 2 hospitals receiving care either before or after the implementation of FFC and the patients informal caregiver as determined by the patient.
- Exclusion Criteria:
- • A life-threatening situation or in a terminal phase upon admission (only applicable to patients)
- • Not mastering the Dutch language;
- • Not able to communicate adequately, based on a below threshold score on the MOCA or the FAST (only applicable to patients)
- • A second hospitalization on one of the participating wards after being included in the study during the study period;
- • An hospitalization \< 48 hours
About Leiden University Medical Center
Leiden University Medical Center (LUMC) is a prominent academic medical center located in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and high-quality patient care. As a clinical trial sponsor, LUMC focuses on translating scientific discoveries into effective therapies, fostering collaborations between researchers, clinicians, and industry partners. The center is dedicated to conducting rigorous clinical studies across various medical fields, ensuring adherence to ethical standards and regulatory requirements while prioritizing patient safety and outcomes. Through its multidisciplinary approach, LUMC aims to contribute significantly to the understanding and treatment of complex health conditions, driving progress in personalized medicine and improving global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, , Netherlands
Leiden, Zuid Holland, Netherlands
Doetinchem, , Netherlands
Patients applied
Trial Officials
Janneke M de Man - van Ginkel
Principal Investigator
Leiden University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported